Qiqihar First Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• COPD2 trials
• Colorectal cancer1 trial
• Coronary artery disease1 trial
• Heart failure1 trial

Phase

• Phase 33 trials
• Phase 1/21 trial

Status

• Not yet recruiting3 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
• Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
• Harbin Medical University1 trial
• Zensun Sci. & Tech. Co., Ltd.1 trial

Running trials

• Recruiting

  A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.

  NCT07653685· Phase 1/2· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

  Contact: Xiyuan Sun, Doctor

• Recruiting

  Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

  NCT07567625· Harbin Medical University· Source

  Contact: Jinhui Zhang

• Recruiting

  Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

  NCT07464587· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

  Contact: Jian Ding, Master

• Not yet recruiting

  Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

  NCT07147946· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

  Contact: Jian Ding, Master

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD2 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting

Closed trials

• Completed

  Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

  NCT05949801· Phase 3· Zensun Sci. & Tech. Co., Ltd.· Source